Persimmune

Blood & Organ Banks · California, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

11575 Sorrento Valley Rd Ste 204, San Di...

Phone Number

(858) 704-4499

Revenue

<$5 Million

Industry

Blood & Organ Banks Business Services Healthcare Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1

About Persimmune

PersImmune is a clinical-stage immunotherapy company focused on personalized adoptive T-cell therapy targeting neoantigens for cancer patients. They aim to address the unique characteristics of individual cancers by employing a proprietary protocol that generates highly-specific T-cells based on the patient's unique tumor DNA alterations. Their approach seeks to minimize side effects compared to traditional immunotherapy and chemotherapy methods. Currently, PersImmune is conducting a Phase 1 clinical trial for patients with suspected or diagnosed myelodysplastic syndromes (MDS) in collaboration with prominent cancer research centers.Explore more
Persimmune's Social MediaPopular SearchesPersImmune IncPersimmuneSIC Code 28,283NAICS Code 32,325Show more

Persimmune Org Chart

PhoneEmail
MV
United States flag for contact location.

Research Scientist

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Persimmune your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Persimmune

Compare insights from companies similar to Persimmune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Persimmune

<$5M
1-10
Private
-
2010
MV
Marina VoronchikhinaResearch Scientist
<$5M
11-50
Public
$10.6M
2015
Walter Klemp, Founder, President, Chief Executive Officer  & Chairman at Moleculin
Walter KlempFounder, President, CEO & Chairman
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
AW
Alfred WinklerUrologic Oncologist (GU Cancer Surgeon)
<$5M
1-10
Private
-
2012
LH
Lauren HartmannManager, Clinical Trial & Consultant
<$5M
11-50
Public
$27.2M
2009
Illustration of an envelope

Company Profile Activity

i

Among all Healthcare Services companies

Low Activity

High Activity

Activity Insights

Persimmune is experiencing very low activity levels compared to other companies in the Healthcare Services sector.

What does this means?

Persimmune is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Persimmune.

Persimmune Tech Stack

A closer look at the technologies used by Persimmune

Top Blood & Organ Banks Companies

Frequently Asked Questions Regarding Persimmune

What is Persimmune's official website?
Persimmune's official website is www.persimmune.com
What is Persimmune's Revenue?
Persimmune's revenue is <$5 Million
What is Persimmune's SIC code?
Persimmune's SIC: 28,283
What is Persimmune's NAICS code?
Persimmune's NAICS: 32,325
How many employees does Persimmune have?
Persimmune has 1-10 employees
What industry does Persimmune belong to?
Persimmune is in the industry of: Blood & Organ Banks, Business Services, Healthcare Services
What is Persimmune competition?
Persimmune top competitors include: Testicular Cancer, Veana Therapeutics, Moleculin, Myelofibrosis Neoplasms
What technology does Persimmune use?
Some of the popular technologies that Persimmune uses are: WordPress.org, PHP, F5 Silverline DDoS Protection, Google Font API
How do I contact Persimmune?
Persimmune contact info: Phone number: (858) 704-4499 Website: www.persimmune.com
What does Persimmune do?

PersImmune is a clinical-stage immunotherapy company focused on personalized adoptive T-cell therapy targeting neoantigens for cancer patients. They aim to address the unique characteristics of individual cancers by employing a proprietary protocol that generates highly-specific T-cells based on the patient's unique tumor DNA alterations. Their app... roach seeks to minimize side effects compared to traditional immunotherapy and chemotherapy methods. Currently, PersImmune is conducting a Phase 1 clinical trial for patients with suspected or diagnosed myelodysplastic syndromes (MDS) in collaboration with prominent cancer research centers.Read More

What are Persimmune social media links?
Persimmune Linkedin page Persimmune Twitter page
Is Persimmune a public company?
Persimmune is private company therefore does not currently have an official ticker symbol
See more information about Persimmune

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.